Salvianolate injection for hypertensive nephropathy patients who were using valsartan: A systematic review and meta-analysis.

ABSTRACT: Background: The treatment of hypertensive nephropathy has remained unchanged for many years. Salvianolate is the main active component extracted from Salvia Miltiorrhiza. The current studies seem to suggest that salvianolate has a certain therapeutic effect on hypertensive nephropathy. Objective: The purpose of this meta-analysis is to evaluate the effect and safety of salvianolate on hypertensive nephropathy under the condition of standardized use of valsartan. Methods: We conducted a systematic search (unlimited initial date to 22 October 2022) in PubMed, Web of Science, the Cochrane Library, Embase, China National Knowledge Infrastructure, Wanfang Data knowledge service platform, China Science and Technology Journal Database, China Biomedical Literature Servi

SUBMITTER: Xu Q 

PROVIDER: S-EPMC9922779 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature